NETO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.726000E-01
Normal-vs-Stage2
3.645000E-01
Normal-vs-Stage3
2.838200E-01
Normal-vs-Stage4
8.418200E-01
Stage1-vs-Stage2
6.39749999642447E-08
Stage1-vs-Stage3
2.336600E-01
Stage1-vs-Stage4
2.055400E-01
Stage2-vs-Stage3
5.115000E-01
Stage2-vs-Stage4
5.237800E-01
Stage3-vs-Stage4
3.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.438200E-01
Normal-vs-AfricanAmerican
4.624800E-01
Normal-vs-Asian
3.860800E-01
Caucasian-vs-AfricanAmerican
8.948000E-01
Caucasian-vs-Asian
4.864100E-02
AfricanAmerican-vs-Asian
2.756600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.184600E-01
Normal-vs-Female
7.547600E-01
Male-vs-Female
4.939000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.886800E-01
Normal-vs-Age(41-60Yrs)
7.314400E-01
Normal-vs-Age(61-80Yrs)
6.225800E-01
Normal-vs-Age(81-100Yrs)
3.200000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.878400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.656500E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.086600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.519200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.402000E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.697810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.854600E-01
Normal-vs-Daily Drinker
3.540200E-01
Normal-vs-Weekly Drinker
7.552400E-01
Normal-vs-Occasional Drinker
6.463400E-01
Normal-vs-Social Drinker
3.392000E-01
Non Drinker-vs-Daily Drinker
6.645200E-01
Non Drinker-vs-Weekly Drinker
2.004000E-01
Non Drinker-vs-Occasional Drinker
4.733700E-02
Non Drinker-vs-Social Drinker
4.586800E-01
Daily Drinker-vs-Weekly Drinker
1.506370E-01
Daily Drinker-vs-Occasional Drinker
4.018100E-02
Daily Drinker-vs-Social Drinker
3.214800E-01
Weekly Drinker-vs-Occasional Drinker
1.810760E-01
Weekly Drinker-vs-Social Drinker
4.646800E-01
Occasional Drinker-vs-Social Drinker
8.173600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.829800E-01
Normal-vs-Grade 2
6.508800E-01
Normal-vs-Grade 3
6.722400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.414000E-01
Grade 1-vs-Grade 3
8.866600E-01
Grade 1-vs-Grade 4
5.829800E-01
Grade 2-vs-Grade 3
5.469000E-01
Grade 2-vs-Grade 4
6.508800E-01
Grade 3-vs-Grade 4
6.722400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.679800E-01
Normal-vs-NonDiabetic
7.268800E-01
Diabetic-vs-NonDiabetic
2.697600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.711600E-01
Normal-vs-NoPancreatitis
7.005000E-01
Pancreatitis-vs-NoPancreatitis
2.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.625200E-01
Normal-vs-N1
4.300600E-01
N0-vs-N1
8.814200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.612800E-01
Normal-vs-TP53-NonMutant
7.337600E-01
TP53-Mutant-vs-TP53-NonMutant
4.865400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
